Document Detail

The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures.
MedLine Citation:
PMID:  10642049     Owner:  NLM     Status:  MEDLINE    
Seasonal or circannual rhythms have been reported in various physiologic, biochemical, pharmacological, and toxicological studies in mice and rats despite laboratory conditions with standardized and controlled light cycle, temperature, humidity, and food. This may either be explained by the existence of innate, free-running circannual rhythms or by the existence of seasonally varying environmental factors ('zeitgeber') which are detected by the animals despite controlled laboratory conditions. In the present study, it was evaluated whether circannual rhythms affect the anticonvulsant activity of phenobarbital, carbamazepine, or valproate in two mouse models of generalized seizures, i.e. the threshold for generalized tonic seizures in the maximal electroshock seizure (MES) test and the threshold for different types of generalized seizures induced by the chemical convulsant pentylenetetrazol (PTZ). A study protocol was used with data sampling in separate groups of mice per month (using each group only once) over a period of 13 months beginning and ending in late summer (September), so that data collected in the other seasons could be compared with summer values of 2 subsequent years. With all three anticonvulsants, marked seasonal variation was observed in both seizure models with lowest anticonvulsant efficacy and potency in March and April, i.e. in late winter and early spring. The most marked loss of anticonvulsant activity in this period of the year was observed with valproate. Analysis of drug levels in plasma and brain indicated that the seasonal variation in phenobarbital's and carbamazepine's anticonvulsant effect was predominantly due to alterations in drug metabolism leading to reduced brain levels in March and April, while the seasonal rhythm in valproate's activity appeared to be mainly related to altered pharmacodynamic activity. These findings indicate that the time of the year is an important variable in the experimental evaluation of anticonvulsant drugs. Furthermore, the present data add to the accumulating evidence that endogenous circannual rhythms should be considered during animal experiments under controlled laboratory conditions.
W Löscher; M Fiedler
Related Documents :
3149359 - Acute effects of sodium valproate on epileptic photosensitivity in the lateral genicula...
6702419 - Should alcohol withdrawal seizures be treated with anti-epileptic drugs?
25102089 - Long-acting three-drug combination anti-hiv nanoparticles enhance drug exposure in prim...
23744599 - Recent findings on the mechanisms involved in tenofovir resistance.
23719679 - The role of pharmacogenetics in drug disposition and response of oral glucose-lowering ...
23920619 - Development of description framework of pharmacodynamics ontology and its application t...
2146699 - Effect of acidic ph on radiosensitization of fsaiic cells in vitro by misonidazole, eta...
16542619 - Mechanisms and strategies for prevention in diabetic retinopathy.
16316849 - Compatibility studies between ibuprofen or ketoprofen with cellulose ether polymer mixt...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Epilepsy research     Volume:  38     ISSN:  0920-1211     ISO Abbreviation:  Epilepsy Res.     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-02-14     Completed Date:  2000-02-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8703089     Medline TA:  Epilepsy Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  231-48     Citation Subset:  IM    
Department of Pharmacology, Toxicology, and Pharmacy, School of Veterinary Medicine, Hannover, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticonvulsants / pharmacology,  therapeutic use*
Carbamazepine / pharmacology,  therapeutic use
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Phenobarbital / pharmacology,  therapeutic use
Seizures / drug therapy*,  physiopathology
Valproic Acid / pharmacology,  therapeutic use
Reg. No./Substance:
0/Anticonvulsants; 298-46-4/Carbamazepine; 50-06-6/Phenobarbital; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early magnetic field changes preceding the intracortical penicillin induced spikes.
Next Document:  Can a generalized kindling seizure induce a reward state?